TCRX
Tscan Therapeutics Inc
NASDAQ: TCRX · HEALTHCARE · BIOTECHNOLOGY
$1.15
-8.73% today
Updated 2026-04-29
Market cap
$75.73M
P/E ratio
—
P/S ratio
7.33x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
Tscan Therapeutics Inc (TCRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |